PMGC Holdings Inc. (ELAB) stock
ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.48−0.18 (-10.84%)
Close on Nov 17, 2026Market cap $1.32MP/E –Yield –
PMGC cash
Cash and short-term investments held at the end of each period.
PMGC's cash was $13.53M at Sep 30, 2026. For fiscal 2025 it was $5.97M, up 49.9% from the year before. The highest annual figure on record is $5.97M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.97M | +49.9% |
| FY2024 | Dec 31, 2024 | $3.98M | +19.8% |
| FY2023 | Dec 31, 2023 | $3.33M | +188.1% |
| FY2022 | Dec 31, 2022 | $1.15M | +180.4% |
| FY2021 | Dec 31, 2021 | $411.86K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $13.53M | +59.1% |
| Q2 FY2026 | Jun 30, 2026 | $18.79M | +197.9% |
| Q1 FY2026 | Mar 31, 2026 | $15.09M | +154.8% |
| Q4 FY2025 | Dec 31, 2025 | $5.97M | +49.9% |
| Q3 FY2025 | Sep 30, 2025 | $8.50M | +32.4% |
| Q2 FY2025 | Jun 30, 2025 | $6.31M | +6205.3% |
| Q1 FY2025 | Mar 31, 2025 | $5.92M | +527.4% |
| Q4 FY2024 | Dec 31, 2024 | $3.98M | +19.8% |
| Q3 FY2024 | Sep 30, 2024 | $6.43M | +1247.5% |
| Q2 FY2024 | Jun 30, 2024 | $100.03K | -83.4% |
| Q1 FY2024 | Mar 31, 2024 | $943.80K | -9.8% |
| Q4 FY2023 | Dec 31, 2023 | $3.33M | +188.1% |
| Q3 FY2023 | Sep 30, 2023 | $476.86K | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $601.27K | +46.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.05M | – |
| Q4 FY2022 | Dec 31, 2022 | $1.15M | – |
| Q3 FY2022 | Sep 30, 2022 | $1.57B | – |
| Q4 FY2021 | Dec 31, 2021 | $411.86K | – |
See a number that looks wrong?